Beijing Zhong Lun Law Firm's Legal Opinion on the Partial Cancellation of Restricted Stock Repurchase of China Resources Double-Crane Pharmaceutical Co., Ltd.'s 2021 Restricted Stock Incentive Plan.

SZSI · Aug 23

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

北京市中伦律师事务所关于华润双鹤药业股份有限公司2021年限制性股票激励计划部分限制性股票回购注销的法律意见书

Beijing Zhong Lun Law Firm's Legal Opinion on the Partial Cancellation of Restricted Stock Repurchase of China Resources Double-Crane Pharmaceutical Co., Ltd.'s 2021 Restricted Stock Incentive Plan.

Risk Disclaimer

Statement